Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
use increased » cases increased (Expand Search), also increased (Expand Search), rate increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
use increased » cases increased (Expand Search), also increased (Expand Search), rate increased (Expand Search)
-
701
-
702
<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation.
Published 2025“…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …”
-
703
-
704
-
705
Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas
Published 2025“…Moreover, annual colony losses also decreased with higher abundance of surrounding forested area. …”
-
706
-
707
5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection.
Published 2024Subjects: -
708
The influence of 5-HT in mice serum on <i>Plasmodium</i> infection in mosquitoes.
Published 2024Subjects: -
709
-
710
-
711
The influence of <i>PINK1</i> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>.
Published 2024Subjects: -
712
-
713
The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis.
Published 2024Subjects: -
714
-
715
-
716
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
717
The disease burden of AA caused by hypertension in 204 countries and regions.
Published 2025Subjects: -
718
The ASDR of AA caused by hypertension in 204 countries and regions in 2021.
Published 2025Subjects: -
719
-
720